Follow-The-Filings

INBX Inhibrx Biosciences

Inhibrx Biosciences earnings company data as of 7:30 PM ET 8/20

History

1 period · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q2 13 Aug EPS -2.34
Rev

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q 10-Q
8-K 2.02,9.01
8-K 1.01,2.03,3.02,7.01,9.01
8-K 7.01,8.01,9.01
8-K 5.07
10-Q 10-Q
8-K 2.02,9.01
8-K 7.01,8.01,9.01
DEFA14A DEFA14A
8-K 7.01,8.01,9.01
10-K 10-K
8-K 2.02,9.01
8-K 7.01,9.01
8-K 7.01,8.01,9.01
10-Q 10-Q
8-K 2.02,9.01
8-K 7.01,8.01,9.01
10-Q 10-Q
8-K 2.02,9.01
8-K 5.07
424B3 424B3
10-Q 10-Q
8-K 2.02,9.01
424B3 424B3
DEFA14A DEFA14A

Insider forms

Form 3 / 4 / 5 from EDGAR · 5 of 13 shown

Filed Form Detail Links
4 Period Jun 3, 2026 · 4 forms
4 Period Apr 24, 2026

8 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice